This lower molecular weight isoform product of native PRL impairs functional tumor neovascularization by altering Notch signaling, particularly due to its inhibitory effect on vessel maturation through its binding to fibrinolytic inhibitor plasminogen activator inhibitor-1 (PAI-1). This evidence concerns the gene SERPINE1 and neoplasm.